| General information | Experimental group | Reference group | t/x2 | P | |
| gender | man | 16 | 18 | 0.251 | >0.05 |
| woman | 16 | 14 | |||
| Average age | 46.30 ± 5.36 | 46.28 ± 5.31 | 0.015 | >0.05 | |
| Mean course of illness | 3.55 ± 1.36 | 3.51 ± 1.32 | 0.067 | >0.05 | |
| by stages | Phase I | 9 | 8 | 0.275 | >0.05 |
| Stage II | 15 | 17 | |||
| Stage III | 6 | 5 | |||